Pre-order Enquiry
Request Free Sample
Global Pegfilgrastim Biosimilar Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18657776 | Publishing Date : 28-Jun-2021 | No. of pages : 117
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Pegfilgrastim Biosimilar Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Pegfilgrastim Biosimilar Market Overview1.1 Pegfilgrastim Biosimilar Product Overview
1.2 Pegfilgrastim Biosimilar Market Segment by Type
1.2.1 Chemotherapy Treatment
1.2.2 Transplantation
1.3 Global Pegfilgrastim Biosimilar Market Size by Type
1.3.1 Global Pegfilgrastim Biosimilar Market Size Overview by Type (2016-2027)
1.3.2 Global Pegfilgrastim Biosimilar Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Pegfilgrastim Biosimilar Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Pegfilgrastim Biosimilar Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Pegfilgrastim Biosimilar Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Pegfilgrastim Biosimilar Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Pegfilgrastim Biosimilar Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Pegfilgrastim Biosimilar Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Pegfilgrastim Biosimilar Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pegfilgrastim Biosimilar Sales Breakdown by Type (2016-2021)
1.4.2 Europe Pegfilgrastim Biosimilar Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Pegfilgrastim Biosimilar Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Pegfilgrastim Biosimilar Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Pegfilgrastim Biosimilar Sales Breakdown by Type (2016-2021)
2 Global Pegfilgrastim Biosimilar Market Competition by Company
2.1 Global Top Players by Pegfilgrastim Biosimilar Sales (2016-2021)
2.2 Global Top Players by Pegfilgrastim Biosimilar Revenue (2016-2021)
2.3 Global Top Players Pegfilgrastim Biosimilar Price (2016-2021)
2.4 Global Top Manufacturers Pegfilgrastim Biosimilar Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pegfilgrastim Biosimilar Market Competitive Situation and Trends
2.5.1 Pegfilgrastim Biosimilar Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Pegfilgrastim Biosimilar Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pegfilgrastim Biosimilar as of 2020)
2.7 Date of Key Manufacturers Enter into Pegfilgrastim Biosimilar Market
2.8 Key Manufacturers Pegfilgrastim Biosimilar Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pegfilgrastim Biosimilar Status and Outlook by Region
3.1 Global Pegfilgrastim Biosimilar Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Pegfilgrastim Biosimilar Historic Market Size by Region
3.2.1 Global Pegfilgrastim Biosimilar Sales in Volume by Region (2016-2021)
3.2.2 Global Pegfilgrastim Biosimilar Sales in Value by Region (2016-2021)
3.2.3 Global Pegfilgrastim Biosimilar Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Pegfilgrastim Biosimilar Forecasted Market Size by Region
3.3.1 Global Pegfilgrastim Biosimilar Sales in Volume by Region (2022-2027)
3.3.2 Global Pegfilgrastim Biosimilar Sales in Value by Region (2022-2027)
3.3.3 Global Pegfilgrastim Biosimilar Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Pegfilgrastim Biosimilar by Application
4.1 Pegfilgrastim Biosimilar Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Mail-Order Pharmacies
4.1.3 Retail Pharmacies
4.2 Global Pegfilgrastim Biosimilar Market Size by Application
4.2.1 Global Pegfilgrastim Biosimilar Market Size Overview by Application (2016-2027)
4.2.2 Global Pegfilgrastim Biosimilar Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Pegfilgrastim Biosimilar Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Pegfilgrastim Biosimilar Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Pegfilgrastim Biosimilar Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Pegfilgrastim Biosimilar Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Pegfilgrastim Biosimilar Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Pegfilgrastim Biosimilar Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Pegfilgrastim Biosimilar Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pegfilgrastim Biosimilar Sales Breakdown by Application (2016-2021)
4.3.2 Europe Pegfilgrastim Biosimilar Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Pegfilgrastim Biosimilar Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Pegfilgrastim Biosimilar Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Pegfilgrastim Biosimilar Sales Breakdown by Application (2016-2021)
5 North America Pegfilgrastim Biosimilar by Country
5.1 North America Pegfilgrastim Biosimilar Historic Market Size by Country
5.1.1 North America Pegfilgrastim Biosimilar Sales in Volume by Country (2016-2021)
5.1.2 North America Pegfilgrastim Biosimilar Sales in Value by Country (2016-2021)
5.2 North America Pegfilgrastim Biosimilar Forecasted Market Size by Country
5.2.1 North America Pegfilgrastim Biosimilar Sales in Volume by Country (2022-2027)
5.2.2 North America Pegfilgrastim Biosimilar Sales in Value by Country (2022-2027)
6 Europe Pegfilgrastim Biosimilar by Country
6.1 Europe Pegfilgrastim Biosimilar Historic Market Size by Country
6.1.1 Europe Pegfilgrastim Biosimilar Sales in Volume by Country (2016-2021)
6.1.2 Europe Pegfilgrastim Biosimilar Sales in Value by Country (2016-2021)
6.2 Europe Pegfilgrastim Biosimilar Forecasted Market Size by Country
6.2.1 Europe Pegfilgrastim Biosimilar Sales in Volume by Country (2022-2027)
6.2.2 Europe Pegfilgrastim Biosimilar Sales in Value by Country (2022-2027)
7 Asia-Pacific Pegfilgrastim Biosimilar by Region
7.1 Asia-Pacific Pegfilgrastim Biosimilar Historic Market Size by Region
7.1.1 Asia-Pacific Pegfilgrastim Biosimilar Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Pegfilgrastim Biosimilar Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Pegfilgrastim Biosimilar Forecasted Market Size by Region
7.2.1 Asia-Pacific Pegfilgrastim Biosimilar Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Pegfilgrastim Biosimilar Sales in Value by Region (2022-2027)
8 Latin America Pegfilgrastim Biosimilar by Country
8.1 Latin America Pegfilgrastim Biosimilar Historic Market Size by Country
8.1.1 Latin America Pegfilgrastim Biosimilar Sales in Volume by Country (2016-2021)
8.1.2 Latin America Pegfilgrastim Biosimilar Sales in Value by Country (2016-2021)
8.2 Latin America Pegfilgrastim Biosimilar Forecasted Market Size by Country
8.2.1 Latin America Pegfilgrastim Biosimilar Sales in Volume by Country (2022-2027)
8.2.2 Latin America Pegfilgrastim Biosimilar Sales in Value by Country (2022-2027)
9 Middle East and Africa Pegfilgrastim Biosimilar by Country
9.1 Middle East and Africa Pegfilgrastim Biosimilar Historic Market Size by Country
9.1.1 Middle East and Africa Pegfilgrastim Biosimilar Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Pegfilgrastim Biosimilar Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Pegfilgrastim Biosimilar Forecasted Market Size by Country
9.2.1 Middle East and Africa Pegfilgrastim Biosimilar Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Pegfilgrastim Biosimilar Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Pegfilgrastim Biosimilar Business
10.1 Novartis
10.1.1 Novartis Corporation Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Novartis Pegfilgrastim Biosimilar Products Offered
10.1.5 Novartis Recent Development
10.2 Mylan
10.2.1 Mylan Corporation Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Novartis Pegfilgrastim Biosimilar Products Offered
10.2.5 Mylan Recent Development
10.3 Coherus BioSciences
10.3.1 Coherus BioSciences Corporation Information
10.3.2 Coherus BioSciences Introduction and Business Overview
10.3.3 Coherus BioSciences Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Coherus BioSciences Pegfilgrastim Biosimilar Products Offered
10.3.5 Coherus BioSciences Recent Development
10.4 Mundipharma International
10.4.1 Mundipharma International Corporation Information
10.4.2 Mundipharma International Introduction and Business Overview
10.4.3 Mundipharma International Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Mundipharma International Pegfilgrastim Biosimilar Products Offered
10.4.5 Mundipharma International Recent Development
10.5 Biocon
10.5.1 Biocon Corporation Information
10.5.2 Biocon Introduction and Business Overview
10.5.3 Biocon Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Biocon Pegfilgrastim Biosimilar Products Offered
10.5.5 Biocon Recent Development
10.6 Intas Pharmaceuticals
10.6.1 Intas Pharmaceuticals Corporation Information
10.6.2 Intas Pharmaceuticals Introduction and Business Overview
10.6.3 Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Intas Pharmaceuticals Pegfilgrastim Biosimilar Products Offered
10.6.5 Intas Pharmaceuticals Recent Development
10.7 Pfizer
10.7.1 Pfizer Corporation Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Pfizer Pegfilgrastim Biosimilar Products Offered
10.7.5 Pfizer Recent Development
10.8 Dr Reddy’s Laboratories
10.8.1 Dr Reddy’s Laboratories Corporation Information
10.8.2 Dr Reddy’s Laboratories Introduction and Business Overview
10.8.3 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Products Offered
10.8.5 Dr Reddy’s Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pegfilgrastim Biosimilar Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pegfilgrastim Biosimilar Industrial Chain Analysis
11.4 Pegfilgrastim Biosimilar Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pegfilgrastim Biosimilar Distributors
12.3 Pegfilgrastim Biosimilar Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Pegfilgrastim Biosimilar Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of Chemotherapy Treatment
Table 2. Major Company of Transplantation
Table 3. Global Pegfilgrastim Biosimilar Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 4. Global Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (K Units)
Table 5. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Type (2016-2021)
Table 6. Global Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (US& Million)
Table 7. Global Pegfilgrastim Biosimilar Market Share in Value by Type (2016-2021)
Table 8. Global Pegfilgrastim Biosimilar Price by Type (2016-2021) & (US$/Unit)
Table 9. Global Pegfilgrastim Biosimilar Sales by Type (2022-2027) & (K Units)
Table 10. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Type (2022-2027)
Table 11. Global Pegfilgrastim Biosimilar Sales by Type (2022-2027) & (US$ Million)
Table 12. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Type (2022-2027)
Table 13. Global Pegfilgrastim Biosimilar Price by Type (2022-2027) & (US$/Unit)
Table 14. North America Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (K Units)
Table 15. North America Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (US$ Million)
Table 16. Europe Pegfilgrastim Biosimilar Sales (K Units) by Type (2016-2021)
Table 17. Europe Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (US$ Million)
Table 18. Asia-Pacific Pegfilgrastim Biosimilar Sales (K Units) by Type (2016-2021)
Table 19. Asia-Pacific Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (US$ Million)
Table 20. Latin America Pegfilgrastim Biosimilar Sales (K Units) by Type (2016-2021)
Table 21. Latin America Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (US$ Million)
Table 22. Middle East and Africa Pegfilgrastim Biosimilar Sales (K Units) by Type (2016-2021)
Table 23. Middle East and Africa Pegfilgrastim Biosimilar Sales by Type (2016-2021) & (US$ Million)
Table 24. Global Pegfilgrastim Biosimilar Sales by Company (2016-2021) & (K Units)
Table 25. Global Pegfilgrastim Biosimilar Sales Share by Company (2016-2021)
Table 26. Global Pegfilgrastim Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 27. Global Pegfilgrastim Biosimilar Revenue Share by Company (2016-2021)
Table 28. Global Market Pegfilgrastim Biosimilar Price by Company (2016-2021) & (US$/Unit)
Table 29. Global Pegfilgrastim Biosimilar Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Pegfilgrastim Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pegfilgrastim Biosimilar as of 2020
Table 32. Date of Key Manufacturers Enter into Pegfilgrastim Biosimilar Market
Table 33. Key Manufacturers Pegfilgrastim Biosimilar Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Pegfilgrastim Biosimilar Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 36. Global Pegfilgrastim Biosimilar Sales by Region (2016-2021) & (K Units)
Table 37. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Region (2016-2021)
Table 38. Global Pegfilgrastim Biosimilar Sales by Region (2016-2021) & (US$ Million)
Table 39. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Region (2016-2021)
Table 40. Global Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 41. Global Pegfilgrastim Biosimilar Sales by Region (2022-2027) & (K Units)
Table 42. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Region (2022-2027)
Table 43. Global Pegfilgrastim Biosimilar Sales by Region (2022-2027) & (US$ Million)
Table 44. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Region (2022-2027)
Table 45. Global Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027)
Table 46. Global Pegfilgrastim Biosimilar Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 47. Global Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (K Units)
Table 48. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Application (2016-2021)
Table 49. Global Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (US$ Million)
Table 50. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Application (2016-2021)
Table 51. Global Pegfilgrastim Biosimilar Price by Application (2016-2021) & (US$/Unit)
Table 52. Global Pegfilgrastim Biosimilar Sales by Application (2022-2027) & (K Units)
Table 53. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Application (2022-2027)
Table 54. Global Pegfilgrastim Biosimilar Sales by Application (2022-2027) & (US$ Million)
Table 55. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Application (2022-2027)
Table 56. Global Pegfilgrastim Biosimilar Price by Application (2022-2027) & (US$/Unit)
Table 57. North America Pegfilgrastim Biosimilar Sales by Application (2016-2021) (K Units)
Table 58. North America Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (US$ Million)
Table 59. North America Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Table 60. Europe Pegfilgrastim Biosimilar Sales by Application (2016-2021) (K Units)
Table 61. Europe Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (US$ Million)
Table 62. Europe Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Table 63. Asia-Pacific Pegfilgrastim Biosimilar Sales by Application (2016-2021) (K Units)
Table 64. Asia-Pacific Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (US$ Million)
Table 65. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Table 66. Latin America Pegfilgrastim Biosimilar Sales by Application (2016-2021) (K Units)
Table 67. Latin America Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (US$ Million)
Table 68. Latin America Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Table 69. Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (2016-2021) (K Units)
Table 70. Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (2016-2021) & (US$ Million)
Table 71. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Table 72. North America Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (K Units)
Table 73. North America Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2016-2021)
Table 74. North America Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (US$ Million)
Table 75. North America Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2016-2021)
Table 76. North America Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (K Units)
Table 77. North America Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2022-2027)
Table 78. North America Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (US$ Million)
Table 79. North America Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2022-2027)
Table 80. Europe Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (K Units)
Table 81. Europe Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2016-2021)
Table 82. Europe Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (US$ Million)
Table 83. Europe Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2016-2021)
Table 84. Europe Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (K Units)
Table 85. Europe Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2022-2027)
Table 86. Europe Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (US$ Million)
Table 87. Europe Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2022-2027)
Table 88. Asia-Pacific Pegfilgrastim Biosimilar Sales by Region (2016-2021) & (K Units)
Table 89. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Volume by Region (2016-2021)
Table 90. Asia-Pacific Pegfilgrastim Biosimilar Sales by Region (2016-2021) & (US$ Million)
Table 91. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Value by Region (2016-2021)
Table 92. Asia-Pacific Pegfilgrastim Biosimilar Sales by Region (2022-2027) & (K Units)
Table 93. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Volume by Region (2022-2027)
Table 94. Asia-Pacific Pegfilgrastim Biosimilar Sales by Region (2022-2027) & (US$ Million)
Table 95. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Value by Region (2022-2027)
Table 96. Latin America Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (K Units)
Table 97. Latin America Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2016-2021)
Table 98. Latin America Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (US$ Million)
Table 99. Latin America Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2016-2021)
Table 100. Latin America Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (K Units)
Table 101. Latin America Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2022-2027)
Table 102. Latin America Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (US$ Million)
Table 103. Latin America Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2022-2027)
Table 104. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (K Units)
Table 105. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2016-2021)
Table 106. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2016-2021)
Table 108. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (K Units)
Table 109. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Volume by Country (2022-2027)
Table 110. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Value by Country (2022-2027)
Table 112. Novartis Corporation Information
Table 113. Novartis Introduction and Business Overview
Table 114. Novartis Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Novartis Pegfilgrastim Biosimilar Product
Table 116. Novartis Recent Development
Table 117. Mylan Corporation Information
Table 118. Mylan Introduction and Business Overview
Table 119. Mylan Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Mylan Pegfilgrastim Biosimilar Product
Table 121. Mylan Recent Development
Table 122. Coherus BioSciences Corporation Information
Table 123. Coherus BioSciences Introduction and Business Overview
Table 124. Coherus BioSciences Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Coherus BioSciences Pegfilgrastim Biosimilar Product
Table 126. Coherus BioSciences Recent Development
Table 127. Mundipharma International Corporation Information
Table 128. Mundipharma International Introduction and Business Overview
Table 129. Mundipharma International Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Mundipharma International Pegfilgrastim Biosimilar Product
Table 131. Mundipharma International Recent Development
Table 132. Biocon Corporation Information
Table 133. Biocon Introduction and Business Overview
Table 134. Biocon Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Biocon Pegfilgrastim Biosimilar Product
Table 136. Biocon Recent Development
Table 137. Intas Pharmaceuticals Corporation Information
Table 138. Intas Pharmaceuticals Introduction and Business Overview
Table 139. Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Intas Pharmaceuticals Pegfilgrastim Biosimilar Product
Table 141. Intas Pharmaceuticals Recent Development
Table 142. Pfizer Corporation Information
Table 143. Pfizer Introduction and Business Overview
Table 144. Pfizer Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Pfizer Pegfilgrastim Biosimilar Product
Table 146. Pfizer Recent Development
Table 147. Dr Reddy’s Laboratories Corporation Information
Table 148. Dr Reddy’s Laboratories Introduction and Business Overview
Table 149. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product
Table 151. Dr Reddy’s Laboratories Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Pegfilgrastim Biosimilar Market Trends
Table 155. Pegfilgrastim Biosimilar Market Drivers
Table 156. Pegfilgrastim Biosimilar Market Challenges
Table 157. Pegfilgrastim Biosimilar Market Restraints
Table 158. Pegfilgrastim Biosimilar Distributors List
Table 159. Pegfilgrastim Biosimilar Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Pegfilgrastim Biosimilar Product Picture
Figure 2. Global Pegfilgrastim Biosimilar Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Pegfilgrastim Biosimilar Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Pegfilgrastim Biosimilar Sales Status and Outlook (2016-2027) & (K Units)
Figure 5. Product Picture of Chemotherapy Treatment
Figure 6. Global Chemotherapy Treatment Sales YoY Growth (2016-2021) & (K Units)
Figure 7. Product Picture of Transplantation
Figure 8. Global Transplantation Sales YoY Growth (2016-2021) & (K Units)
Figure 9. Global Pegfilgrastim Biosimilar Sales by Type (2016-2027) & (US$ Million)
Figure 10. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Type (2016-2021)
Figure 11. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Type (2016-2021)
Figure 12. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Type (2022-2027)
Figure 13. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Type (2022-2027)
Figure 14. North America Pegfilgrastim Biosimilar Sales Market Share in Volume by Type in 2020
Figure 15. North America Pegfilgrastim Biosimilar Sales Market Share in Value by Type in 2020
Figure 16. Europe Pegfilgrastim Biosimilar Sales Market Share in Volume by Type in 2020
Figure 17. Europe Pegfilgrastim Biosimilar Sales Market Share in Value by Type in 2020
Figure 18. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Volume by Type in 2020
Figure 19. Asia-Pacific Pegfilgrastim Biosimilar Sales Market Share in Value by Type in 2020
Figure 20. Latin America Pegfilgrastim Biosimilar Sales Market Share in Volume by Type in 2020
Figure 21. Latin America Pegfilgrastim Biosimilar Sales Market Share in Value by Type in 2020
Figure 22. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Volume by Type in 2020
Figure 23. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Value by Type in 2020
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Pegfilgrastim Biosimilar Sales in 2020
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Pegfilgrastim Biosimilar Revenue in 2020
Figure 26. Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 27. Product Picture of Hospital Pharmacies
Figure 28. Global Hospital Pharmacies Sales YoY Growth (2016-2027) & (K Units)
Figure 29. Product Picture of Mail-Order Pharmacies
Figure 30. Global Mail-Order Pharmacies Sales YoY Growth (2016-2027) & (K Units)
Figure 31. Product Picture of Retail Pharmacies
Figure 32. Global Retail Pharmacies Sales YoY Growth (2016-2027) & (K Units)
Figure 33. Global Pegfilgrastim Biosimilar Sales by Application (2016-2027) & (US$ Million)
Figure 34. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Application (2016-2021)
Figure 35. Global Pegfilgrastim Biosimilar Sales Market Share in Value by Application (2016-2021)
Figure 36. Global Pegfilgrastim Biosimilar Sales Market Share in Volume by Application (2022-2027)
Figure 37. North America Pegfilgrastim Biosimilar Sales Market Share in Volume by Application in 2020
Figure 38. Latin America Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Figure 39. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share in Value by Application in 2020
Figure 40. Key Raw Materials Price
Figure 41. Pegfilgrastim Biosimilar Manufacturing Cost Structure
Figure 42. Pegfilgrastim Biosimilar Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Pegfilgrastim Biosimilar Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
NovartisMylan
Coherus BioSciences
Mundipharma International
Biocon
Intas Pharmaceuticals
Pfizer
Dr Reddy’s Laboratories
